ISS is adopting a metric that may impact how investors evaluate pay practices. Companies that don’t use it already should consider doing so.
Attempts to fix a sales force's incentive plan often just create additional problems.
Should publicly held, early stage biotechs issue more shares or partner with Big Pharma?
They're great for investment bankers and sellers, but lower valuation multiples are associated with greater shareholder return.
Performance metrics related to improvement or growth demonstrate the most positive relationships to shareholder return.
To drive shareholder returns in health care, CFOs should stress financial policies that build financial flexibility rather than leverage.
The CFO and the finance team have the skills to help the CEO understand and interpret residual cash earnings signals.
Price is what you pay, but value is what you get.
Selling idle operating assets below net book value for cash is at worst irrelevant and at best will boost the value and hence the stock price of a…
Price is an outcome, not an input.